Skip to content
Screener

Viking Therapeutics VKTX Asset turnover

Asset turnover at other companies

Eli Lilly logo
Eli LillyLLY
0.7×0.0×
Pfizer logo
PfizerPFE
0.3×0.0×
Amgen logo
AmgenAMGN
0.4×0.0×
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
0.7×-0.1×
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
1.1×+0.6×
VAN
Vivani MedicalVANI
0×—

Other financials

Income statement

See full
Revenue-—
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$3.88B+8.4%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0×0.0×
Current ratio5.7×-38.5×

Where this comes from

Calculated from Viking Therapeutics’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →

Filed
Apr 29, 2026, 9:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-193315

FAQ

What is Viking Therapeutics's asset turnover?
Viking Therapeutics (VKTX) reported asset turnover of 0× in Q1 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Viking Therapeutics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude